Rosiglitazone treatment of patients with extreme insulin resistance and diabetes mellitus due to insulin receptor mutations has no effects on glucose and lipid metabolism.

Saved in:
Bibliographic Details
Title: Rosiglitazone treatment of patients with extreme insulin resistance and diabetes mellitus due to insulin receptor mutations has no effects on glucose and lipid metabolism.
Authors: Vestergaard, H.1, Lund, S.2, Pedersen, O.2
Source: Journal of Internal Medicine. Nov2001, Vol. 250 Issue 5, p406-414. 9p.
Database: Academic Search Ultimate
Description
ISSN:09546820
DOI:10.1046/j.1365-2796.2001.00898.x